CMAJ OPEN, 4(1) E95D iabetic retinopathy is a sight-threatening complication in patients with diabetes mellitus that is usually asymptomatic in the early stages. 1 Effective treatment exists, with over 50% of patients experiencing reduction of severe vision loss if they receive treatment after timely diagnosis.
2About 50% of patients with diabetes do not receive eye examinations as recommended by the American Academy of Ophthalmology.3 This results in lost opportunities to prevent severe vision loss by means of timely treatment delivery. 4 In addition to nonmodifiable factors, limited availability of eye care specialists, travelling difficulties and time constraints also contribute to nonadherence, especially in nonurban areas. 5,6 Pharmacy-based teleophthalmology has emerged as a possible alternative to in-person examinations that may facilitate compliance with evidence-based recommendations and reduce barriers to specialized eye care. 7,8 In a pharmacy-based teleophthalmology program, retinal digital images are captured in a local pharmacy and are securely transmitted electronically to a specialized reading centre, where photographs are graded by an eye specialist.9 Patients with signs of diabetic retinopathy can then be referred to an eye care professional Background: Diabetic eye complications are the leading cause of visual loss among working-aged people. Pharmacy-based teleophthalmology has emerged as a possible alternative to in-person examination that may facilitate compliance with evidence-based recommendations and reduce barriers to specialized eye care. The objective of this study was to estimate the cost-effectiveness of mobile teleophthalmology screening compared with in-person examination (primary care) for the diabetic population residing in semiurban areas of southwestern Ontario.